• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23371 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     Agency for Healthcare Research and Quality (AHRQ) Safety of probiotics used to reduce risk and prevent or treat disease
2011     Agency for Healthcare Research and Quality (AHRQ) Disease-modifying antirheumatic drugs (DMARDs) in children with juvenile idiopathic arthritis (JIA)
2011     NIHR Horizon Scanning Centre (NIHR HSC) Infrared lasers for treating onychomycosis
2011     HAYES, Inc. Botulinum toxin treatment for detrusor instability
2011     National Institute for Health and Care Excellence (NICE) Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome. NICE interventional procedures guidance 376
2011     Agency for Healthcare Research and Quality (AHRQ) Off-label use of atypical antipsychotics: an update
2011     NIHR Horizon Scanning Centre (NIHR HSC) Golimumab (Simponi) for ulcerative colitis - second line
2011     HAYES, Inc. Capsule endoscopy for the diagnosis of small bowel Crohn's disease
2011     National Institute for Health and Care Excellence (NICE) Off-pump coronary artery bypass grafting. NICE interventional procedures guidance 377
2011     Agency for Healthcare Research and Quality (AHRQ) Enabling medication management through health information technology
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Individual health services]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Infliximab (Remicade) for paediatric ulcerative colitis
2011     HAYES, Inc. Computer-aided detection of pulmonary embolism
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of inverted shoulder prosthesis for arthropathy of the rotator cuff: systematic review of the literature and appropriateness criteria]
2011     National Institute for Health and Care Excellence (NICE) Percutaneous laser coronary angioplasty. NICE interventional procedures guidance 378
2011     NIHR Horizon Scanning Centre (NIHR HSC) Amniotic Fluid Lactate monitoring system for dysfunctional labour
2011     HAYES, Inc. Computer-Aided Semen Analysis (CASA) for the diagnosis of male infertility
2011     National Institute for Health and Care Excellence (NICE) Thoracoscopic repair of congenital diaphragmatic hernia in neonates. NICE interventional procedures guidance 379
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of alcohol misuse among children, youths and young adults]
2011     HAYES, Inc. Previstage GCC colorectal cancer staging test
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Prevention of alcohol misuse among children, youths and young adults]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Placental growth factor based tests for the diagnosis of pre-eclampsia
2011     HAYES, Inc. Electrocardiogram signal analysis for diagnosis of coronary artery disease: body surface mapping
2011     Andalusian Health Technology Assessment Area (AETSA) [Paediatric triage systems in hospital emergency department: reliability and validity]
2011     National Institute for Health and Care Excellence (NICE) Distal iliotibial band lengthening for refractory greater trochanteric pain syndrome. NICE interventional procedures guidance 375
2011     Agency for Healthcare Research and Quality (AHRQ) A framework for "best evidence" approaches in systematic reviews
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of interventions in workplace health promotion as to maintain the working capacity of health care personnel]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) for advanced gastric cancer - second line
2011     HAYES, Inc. Electrocardiogram signal-based analysis for diagnosis of coronary artery disease: multifunction cardiogram and signal-averaged electrocardiogram
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Validity of surrogate endpoints in oncology (Rapid report)]
2011     Agency for Healthcare Research and Quality (AHRQ) Health literacy interventions and outcomes: an updated systematic review
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris]
2011     NIHR Horizon Scanning Centre (NIHR HSC) GSK1120212 for unresectable or metastatic melanoma, BRAF V600 mutation-positive in adults
2011     HAYES, Inc. Functional electrical stimulation for rehabilitation following spinal cord injury
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Validity of surrogate endpoints in oncology (Rapid report v. 1.1)]
2011     NIHR Horizon Scanning Centre (NIHR HSC) GSK2118436 (dabrafenib) for malignant melanoma: advanced and/or metastatic (stage III or IV), BRAF V600E mutation - first line
2011     HAYES, Inc. Intensive behavioral intervention therapy for autism
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dipyridamole and aspirin for secondary prevention after stroke or TIA]
2011     HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Effectiveness of programmes as part of primary prevention demonstrated on the example of cardiovascular diseases and the metabolic syndrome]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib for metastatic colorectal cancer - third or fourth line
2011     HAYES, Inc. Local injection therapy and neurosurgery for cervicogenic headache and occipital neuralgia
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in head and neck tumours]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Over-, under- and misuse of pain treatment in Germany]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for hepatocellular carcinoma - adjuvant therapy
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [What type of evidence is currently being considered in the development of clinical practice guidelines for rare diseases? - rapid report]
2011     NIHR Health Technology Assessment programme Cabazitaxel for the second-line treatment of hormone refractory, metastatic prostate cancer: a single technology appraisal
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [11th Symposium Health Technology Assessment, theoretical practice - practical theory? 17th to 18th March 2011, Cologne]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) in combination with capecitabine for HER2-negative locally advanced or metastatic breast cancer - second line
2011     HAYES, Inc. Meniscal allograft transplantation
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Responder analyses for memantine in Alzheimer's disease - Rapid report]
2011     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Prostate cancer screening
2011     NIHR Health Technology Assessment programme Long-acting exenatide in the management of type 2 diabetes
2011     NIHR Horizon Scanning Centre (NIHR HSC) Exenatide (Byetta) for type 2 diabetes mellitus - in combination with basal insulin
2011     HAYES, Inc. Minimally invasive coronary artery bypass graft surgeries for coronary revascularization
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Search for literature on angiotensin II antagonists and ACE inhibitors]
2011     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Nasopharyngeal carcinoma screening
2011     Belgian Health Care Knowledge Centre (KCE) Economic evaluation of antiviral treatment of chronic hepatitis B in Belgium - Part 2
2011     NIHR Health Technology Assessment programme Ipilimumab for previously treated unresectable malignant melanoma
2011     NIHR Horizon Scanning Centre (NIHR HSC) Aganirsen for pathological corneal neovascularisation
2011     HAYES, Inc. Neuronavigation for intracranial biopsy and intracranial surgery
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Positron emission tomography (PET) in malignant melanoma]
2011     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) HPV DNA-based screening test for cervical cancer
2011     NIHR Health Technology Assessment programme Apixaban for the prevention of venous thromboembolism in people undergoing elective knee and hip replacement surgery
2011     NIHR Horizon Scanning Centre (NIHR HSC) Idebenone (Catena) for leber's hereditary optic neuropathy - first line
2011     HAYES, Inc. Optical coherence tomography for coronary artery plaque characterization and stent evaluation
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of long-term blood glucose lowering to normal levels in patients with diabetes mellitus type 2 - Rapid report]
2011     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Immunochemical faecal occult blood test (IFOBT) for colorectal cancer screening
2011     Belgian Health Care Knowledge Centre (KCE) Home oxygen therapy
2011     NIHR Health Technology Assessment programme Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation: a single technology appraisal
2011     NIHR Horizon Scanning Centre (NIHR HSC) Ranibizumab (Lucentis) for visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia - first line
2011     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for detection of recurrent ovarian cancer
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP diabetes mellitus type 1 and extraction of new, relevant recommendations]
2011     HAYES, Inc. Brachytherapy for breast cancer
2011     NIHR Health Technology Assessment programme Boceprevir for the treatment of genotype 1 chronic hepatitis C
2011     NIHR Horizon Scanning Centre (NIHR HSC) Defibrotide (Defitelio) for hepatic veno-occlusive disease in haematopoietic stem cell transplantation - first line
2011     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and management of soft tissue sarcoma
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Prasugrel in the treatment of acute coronary syndrome]
2011     Belgian Health Care Knowledge Centre (KCE) Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood
2011     Gesundheit Osterreich GmbH (GOeG) [Effectiveness of measures (particularly e-medication) to reduce polypharmacy]
2011     Andalusian Health Technology Assessment Area (AETSA) [Analysis of health and socioeconomic factors influencing the progressive increase in frequentation of hospital emergency services]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Certolizumab pegol (Cimzia) for active ankylosing spondylitis (AS) - second or third line; after intolerance or inadequate response to at least one non-steroidal anti-inflammatory drug (NSAID)
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ezetimibe for hypercholesterolaemia]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (Prolia) for osteoporosis in men
2011     HAYES, Inc. Selective Estrogen Receptor Modulators (SERMs) for chemoprevention of breast cancer
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Reduction of alcohol consumption in essential hypertension - Rapid report]
2011     HAYES, Inc. Cognitive-behavioral therapy for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
2011     NIHR Horizon Scanning Centre (NIHR HSC) Laquinimod for multiple sclerosis: relapsing-remitting - first or second line.
2011     HAYES, Inc. Signal-Averaged Electrocardiogram (SAECG) to identify risk of ventricular tachyarrhythmias and sudden cardiac death
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Reduction of alcohol consumption in essential hypertension - Rapid report]
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Pharyngeal pH monitoring by Dx-pH measurement system]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Teriflunomide for relapsing multiple sclerosis (MS) - first line
2011     HAYES, Inc. Social skills training for autistic spectrum disorders
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of non-drug treatment strategies in patients with essential hypertension: Special diets without the primary aim of reducing weight or salt intake - Rapid report]
2011     HAYES, Inc. Alport syndrome
2011     Andalusian Health Technology Assessment Area (AETSA) [Inclusion of new health technologies into Spanish hospitals]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for atypical haemolytic uraemic syndrome - first line
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Stem cell transplantation for multiple myeloma]
2011     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Effectiveness and safety of electrochemotherapy tumor treatment: Systematic review and meta-analysis]
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation